Alpine Global Management’s Aerie Pharmaceuticals AERI Stock Holding History

Alpine Global Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-71,825	Closed	-$1.09M	–	786
2022 Q3	$1.09M	Buy	+71,825	New	+$835K	0.25%	49
2022 Q1	–	Sell	-12,831	Closed	-$90K	–	829
2021 Q4	$90K	Buy	+12,831	New	+$134K	0.01%	681

Alpine Global Management's AERI Position: Q4 2022 in Review

Alpine Global Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 71,825 shares — an estimated $1.09M sold.

Alpine Global Management first reported a position in AERI in Q4 2021 and held it in 2 quarters. The position peaked at $1.09M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Alpine Global Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Alpine Global Management sold 71,825 Aerie Pharmaceuticals shares in Q4 2022, an estimated $1.09M.
Alpine Global Management first reported a position in Aerie Pharmaceuticals in Q4 2021 and held it in 2 quarters.
Alpine Global Management's Aerie Pharmaceuticals position peaked at $1.09M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Alpine Global Management's 13F filing for Q4 2022, filed 14 Feb 2023.